Zhuhai Rundu Pharmaceutical Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
Zhuhai Rundu Pharmaceutical has a total shareholder equity of CN¥1.1B and total debt of CN¥504.7M, which brings its debt-to-equity ratio to 43.9%. Its total assets and total liabilities are CN¥2.2B and CN¥1.0B respectively. Zhuhai Rundu Pharmaceutical's EBIT is CN¥41.7M making its interest coverage ratio 2.9. It has cash and short-term investments of CN¥190.1M.
Belangrijke informatie
43.9%
Verhouding schuld/eigen vermogen
CN¥504.71m
Schuld
| Rente dekkingsratio | 2.9x |
| Contant | CN¥190.14m |
| Aandelen | CN¥1.15b |
| Totaal verplichtingen | CN¥1.02b |
| Totaal activa | CN¥2.17b |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Zhuhai Rundu Pharmaceutical's (SZSE:002923) Dividend Is Being Reduced To CN¥0.20
May 29
There May Be Reason For Hope In Zhuhai Rundu Pharmaceutical's (SZSE:002923) Disappointing Earnings
May 05There's Reason For Concern Over Zhuhai Rundu Pharmaceutical Co., Ltd.'s (SZSE:002923) Massive 32% Price Jump
Mar 05Analyse van de financiële positie
Kortlopende schulden: 002923's short term assets (CN¥837.1M) exceed its short term liabilities (CN¥440.4M).
Langlopende schulden: 002923's short term assets (CN¥837.1M) exceed its long term liabilities (CN¥575.8M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 002923's net debt to equity ratio (27.4%) is considered satisfactory.
Schuld verminderen: 002923's debt to equity ratio has increased from 3.7% to 43.9% over the past 5 years.
Schuldendekking: 002923's debt is well covered by operating cash flow (46.1%).
Rentedekking: 002923's interest payments on its debt are not well covered by EBIT (2.9x coverage).